Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
APLT Applied Therapeutics Inc
- Stocks
- Healthcare
- NASDAQ: APLT
Price (delayed)
$0.4141
Market cap
$58.63M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.28
Enterprise value
$10.56M
Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company's lead drug candidate,
Highlights
The company's EPS has surged by 85% YoY and by 63% QoQ
The company's net income has surged by 78% YoY and by 59% QoQ
APLT's revenue has surged by 156% year-on-year but it is down by 42% since the previous quarter
The company's gross profit has surged by 156% YoY but it fell by 42% QoQ
The equity has declined by 46% year-on-year and by 36% since the previous quarter
Key stats
What are the main financial stats of APLT
Market
Valuations
Earnings
Shares outstanding
141.58M
Market cap
$58.63M
Enterprise value
$10.56M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.31
Price to sales (P/S)
225.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
39.72
Revenue
$266,000
Gross profit
$266,000
Operating income
-$108.73M
Net income
-$43.51M
EBIT
-$43.51M
EBITDA
-$43.1M
Free cash flow
-$94.03M
Per share
Balance sheet
Liquidity
EPS
-$0.28
EPS diluted
-$0.43
Free cash flow per share
-$0.65
Book value per share
$0.32
Revenue per share
$0
TBVPS
$0.39
Total assets
$56.91M
Total liabilities
$20.24M
Debt
$2.7M
Equity
$36.67M
Working capital
$36M
Debt to equity
0.07
Current ratio
3
Quick ratio
2.83
Net debt/EBITDA
1.12
Margins
Efficiency
Dividend
EBITDA margin
-16,203.4%
Gross margin
100%
Net margin
-16,357.5%
Operating margin
-40,875.9%
Return on assets
-46.1%
Return on equity
-101.2%
Return on invested capital
N/A
Return on capital employed
-111.7%
Return on sales
-16,357.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
APLT stock price
How has the Applied Therapeutics stock price performed over time
Intraday
4.84%
1 week
29.41%
1 month
7.25%
1 year
-92.1%
YTD
-51.64%
QTD
33.11%
Financial performance
How have Applied Therapeutics's revenue and profit performed over time
Revenue
$266,000
Gross profit
$266,000
Operating income
-$108.73M
Net income
-$43.51M
Gross margin
100%
Net margin
-16,357.5%
APLT's revenue has surged by 156% year-on-year but it is down by 42% since the previous quarter
The company's gross profit has surged by 156% YoY but it fell by 42% QoQ
The operating margin has plunged by 78% from the previous quarter
The company's net income has surged by 78% YoY and by 59% QoQ
Price vs fundamentals
How does APLT's price correlate with its fundamentals
Growth
What is Applied Therapeutics's growth rate over time
Valuation
What is Applied Therapeutics stock price valuation
P/E
N/A
P/B
1.31
P/S
225.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
39.72
The company's EPS has surged by 85% YoY and by 63% QoQ
APLT's price to book (P/B) is 97% less than its last 4 quarters average of 44.1
The equity has declined by 46% year-on-year and by 36% since the previous quarter
APLT's revenue has surged by 156% year-on-year but it is down by 42% since the previous quarter
Efficiency
How efficient is Applied Therapeutics business performance
The return on equity has surged by 95% year-on-year and by 51% since the previous quarter
The return on assets has surged by 82% year-on-year and by 48% since the previous quarter
The company's return on sales rose by 30% QoQ
Dividends
What is APLT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for APLT.
Financial health
How did Applied Therapeutics financials performed over time
The company's total assets is 181% higher than its total liabilities
The total liabilities has plunged by 76% YoY and by 32% from the previous quarter
The current ratio has soared by 67% YoY
APLT's debt is 93% smaller than its equity
The equity has declined by 46% year-on-year and by 36% since the previous quarter
The company's debt to equity rose by 40% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.